X-linked Adrenoleukodystrophy (X-ALD) Full Gene Sequencing
X-linked Adrenoleukodystrophy (X-ALD) Full Gene Sequencing
Procedure #
CPT: 81405
| Synonym(s): | X-ALD |
|---|---|
| Requisition Form |
G-1B |
| Test Description | X-linked Adrenoleukodystrophy (X-ALD) Full Gene Sequencing |
| Pre-Approval Needed | N/A |
| Supplemental Information Required | N/A |
| Supplemental Form(s) | N/A |
| Performed on Specimens from (sources) | Human |
| Sample/Specimen Type for Testing |
|
| Minimum Volume/Size Required |
|
| Storage/Preservation Prior to Shipping | Dried filter paper blood specimens
|
| Transport Medium | EDTA acceptable for whole blood |
| Specimen Labeling |
Ship all specimens according to Dangerous Good Regulations, IATA, and/or CFR 49. DRIED FILTER PAPER BLOOD SPECIMENS
WHOLE BLOOD SHIPPING REQUIREMENT
|
| Method | PCR Amplification and Sanger Sequencing |
| Turn-around Time | 14 working days |
| Common Causes for Rejection |
Visit website for complete list. |
| Additional Information | Interpretation: Available on the result report. Diagnostic Information: X-ALD DNA testing is performed in support of the Newborn Screening Program at DSHS and for other individuals. X-ALD Sanger sequencing methodology can detect approximately 97% of the known variants in this gene. Test results should not be used as a diagnostic test, but should be interpreted in the context of clinical findings, family history, and other laboratory data. Additional information for specimen collection: |